Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBIT (2016 - 2018)

Historic EBIT for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$2.8 million.

  • Armata Pharmaceuticals' EBIT fell 1813.95% to -$2.8 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$10.4 million, marking a year-over-year increase of 3543.58%. This contributed to the annual value of -$42.4 million for FY2024, which is 378.09% down from last year.
  • Per Armata Pharmaceuticals' latest filing, its EBIT stood at -$2.8 million for Q4 2018, which was down 1813.95% from -$2.4 million recorded in Q3 2018.
  • In the past 5 years, Armata Pharmaceuticals' EBIT ranged from a high of -$746000.0 in Q3 2017 and a low of -$11.9 million during Q4 2016
  • Its 5-year average for EBIT is -$3.8 million, with a median of -$2.8 million in 2018.
  • Its EBIT has fluctuated over the past 5 years, first crashed by 30353.74% in 2016, then skyrocketed by 8006.57% in 2017.
  • Over the past 5 years, Armata Pharmaceuticals' EBIT (Quarter) stood at -$2.6 million in 2014, then fell by 13.21% to -$2.9 million in 2015, then plummeted by 303.54% to -$11.9 million in 2016, then surged by 80.07% to -$2.4 million in 2017, then fell by 18.14% to -$2.8 million in 2018.
  • Its EBIT was -$2.8 million in Q4 2018, compared to -$2.4 million in Q3 2018 and -$2.8 million in Q2 2018.